Keeping My Promise Led to an Earlier Diagnosis
Yolanda L. Jackson promised her doctor she would get a CT scan of her digestive tract. This led to an early diagnosis of pancreatic cancer.
More Effective Focused Radiation Therapy and Chemotherapy for Locally Advanced Pancreatic Cancer
A clinical trial tests whether adding Zometa makes chemotherapy and stereotactic body radiation therapy (SBRT) more effective against pancreatic cancer.
Far More Time than I Originally Expected
After a Whipple procedure, SBRT, and chemotherapy, Robert Glazier is staying informed about treatment options for pancreatic cancer.
Comparing Chemotherapy and Radiation Regimens to Prevent Recurrence of Pancreatic Cancer
A clinical trial compares standard chemotherapy with gemcitabine to the combination of chemotherapy with capecitabine and radiation.
I Am Alive and Grateful
Ken Parme had chemotherapy and CyberKnife radiation treatment for pancreatic cancer. The treatments have stabilized his tumor.
Chemotherapy Makes Tumor Removal Possible
Anne Seagren In December of 2006 at the age of 56 I became aware of a slight pressure in my side. I decided to follow up with my doctor. She recommended a CT scan to see if I had gallstones or appendicitis. The pressure subsided and I considered ignoring her advice. Fortunately, I went ahead […]
Making a Risky Choice
Judith Zitiello’s pancreatic cancer was wrapped around the hepatic artery, but she chose the laparoscopic Whipple procedure instead of chemotherapy alone.
The Alien Inside Me
Kim Vernick details the clinical trial and surgery used to treat her pancreatic cancer. When the cancer returns she explains the treatment she got.
Low-Dose Continuous Chemotherapy as Part of a New Combination of Drugs
A clinical trial uses a new immunotherapy drug in combination with standard chemotherapy drugs in metronomic therapy to treat metastatic pancreatic cancer.
Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.